Structure-based drug design to augment hit discovery

Drug Discovery Today

Volumn 16, Issue 17-18, 2011, Pages 831-839

  Kalyaanamoorthy, Subha ^a   Chen, Yi Ping Phoebe ^a  

^a LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING SITE; COMPUTER MODEL; DRUG DESIGN; DRUG DEVELOPMENT; DRUG SCREENING; DRUG STRUCTURE; DRUG TARGETING; GENE SEQUENCE; GENETIC SCREENING; HUMAN; MOLECULAR DOCKING; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; STRUCTURE ANALYSIS;

COMPUTATIONAL BIOLOGY; COMPUTER-AIDED DESIGN; DRUG DESIGN; INTERNET; MOLECULAR CONFORMATION; SOFTWARE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 80052858265     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2011.07.006     Document Type: Review

References (57)

1. H. Alonso Combining docking and molecular dynamic simulations in drug design Med. Res. Rev. 26 2006 531 568 (Pubitemid 44230412)
2. G.M. Keseru, and G.M. Makara The influence of lead discovery strategies on the properties of drug candidates Nat. Rev. Drug Discov. 8 2009 203 212
3. J.R.A. Goodnow Hit and lead identification: integrated technology-based approaches Drug Discov. Today: Technol. 3 2006 367 375
4. B. Fischer Receptor Flexibility for Large-Scale In Silico Ligand Screens A. Kukol, Molecular Modeling of Proteins, Vol. 443 2008 Humana Press pp. 353-364
5. J.J. Liao, and R.C. Andrews Targeting protein multiple conformations: a structure-based strategy for kinase drug design Curr. Top. Med. Chem. 7 2007 1394 1407 (Pubitemid 47471237)
6. H. Sun Pharmacophore-based virtual screening Curr. Med. Chem. 15 2008 1018 1024 (Pubitemid 351736404)
7. Y.P.P. Chen, and F. Chen Using bioinformatics techniques for gene identification in drug discovery and development Curr. Drug Metab. 9 2008 567 573 (Pubitemid 352025188)
8. D.B. Searls Data integration: challenges for drug discovery Nat. Rev. Drug Discov. 4 2005 45 58 (Pubitemid 40109589)
9. C. Smith Drug target identification: a question of biology Nature 428 2004 225 231
10. J.N.Y. Chan Recent advances and method development for drug target identification Trends Pharmacol. Sci. 31 2010 82 88
11. M.A. Grant Protein structure prediction in structure-based ligand design and virtual screening Combinatorial Chem. High Throughput Screen. 12 2009 940 960
12. C.M. Song Recent advances in computer-aided drug design Brief Bioinform. 10 2009 579 591
13. E. Krieger Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: four approaches that performed well in CASP8 Proteins Struct. Funct. Bioinform. 77 2009 114 122
14. L. Bordoli Protein structure homology modeling using SWISS-MODEL workspace Nat. Protocols 4 2008 1 13
15. V. Potapov Protein structure modelling and evaluation based on a 4-distance description of side-chain interactions BMC Bioinform. 11 2010 374
16. B. Huang, and M. Schroeder LIGSITEcsc: predicting ligand binding sites using the Connolly surface and degree of conservation BMC Struct. Biol. 6 2006 19
17. A. Laurie, and R. Jackson Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites Bioinformatics 21 2005 1908 1916 (Pubitemid 40668026)
18. T. Binkowski CASTp: computed atlas of surface topography of proteins Nucleic Acids Res. 31 2003 3352 3355 (Pubitemid 37442157)
19. T. Wunberg Improving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hits Drug Discov. Today 11 2006 175 180 (Pubitemid 43375969)
20. R. Kato Novel strategy for protein exploration: high-throughput screening assisted with fuzzy neural network J. Mol. Biol. 351 2005 683 692 (Pubitemid 41021950)
21. K.H. Bleicher Hit and lead generation: beyond high-throughput screening Nat. Rev. Drug Discov. 2 2003 369 378 (Pubitemid 37361707)
22. B.K. Shoichet Virtual screening of chemical libraries Nature 432 2004 862 865 (Pubitemid 40037142)
23. S.S. Phatak High-throughput and in silico screenings in drug discovery Exp. Opin. Drug Discov. 4 2009 947 959
24. A.J. Williams A perspective of publicly accessible/open-access chemistry databases Drug Discov. Today 13 2008 495 501
25. M. Hein Docking compared to 3D-pharmacophores: the scoring function challenge Drug Discov. Today Technol. 7 2010 229 236
26. L.J. Gershell, and J.H. Atkins A brief history of novel drug discovery technologies Nat. Rev. Drug Discov. 2 2003 321 327 (Pubitemid 37361690)
27. D.M. Krüger, and A. Evers Comparison of structure- and ligand-based virtual screening protocols considering hit list complementarity and enrichment factors ChemMedChem 5 2010 148 158
28. I. Muegge, and S. Oloff Advances in virtual screening Drug Discov. Today Technol. 3 2006 405 411 (Pubitemid 46164322)
29. O. Sperandio wwLigCSRre: a 3D ligand-based server for hit identification and optimization Nucleic Acids Res. 37 Suppl. 2 2009 504 509
30. Y. Tang New technologies in computer-aided drug design: toward target identification and new chemical entity discovery Drug Discov. Today Technol. 3 2006 307 313 (Pubitemid 44734724)
31. M.S. Coumar Structure-based drug design of novel aurora kinase A inhibitors: structural basis for potency and specificity J. Med. Chem. 52 2009 1050 1062
32. D.E. Clark What has computer-aided molecular design ever done for drug discovery? Exp. Opin. Drug Discov. 1 2006 103 110
33. T.N. Doman Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B J. Med. Chem. 45 2002 2213 2221 (Pubitemid 34525801)
34. G. Schneider Virtual screening: an endless staircase? Nat. Rev. Drug Discov. 9 2010 273 276
35. G. Thomas Computer-aided drug design G. Thomas, Medicinal Chemistry: An Introduction 2nd Edn. 2007 Wiley pp. 113-143
36. G. Schneider, and U. Fechner Computer-based de novo design of drug-like molecules Nat. Rev. Drug Discov. 4 2005 649 663 (Pubitemid 41149759)
37. G.M. Keseru, and G.M. Makara Hit discovery and hit-to-lead approaches Drug Discov. Today 11 2006 741 748 (Pubitemid 44038630)
38. G. Lauri, and P.A. Bartlett CAVEAT: a program to facilitate the design of organic molecules J. Computer-Aided Mol. Design 8 1994 51 66
39. V.J. Gillet SPROUT: recent developments in the de novo design of molecules J. Chem. Inform. Computer Sci. 34 1994 207 217
40. H.-J. Böhm The computer program LUDI: a new method for the de novo design of enzyme inhibitors J. Computer-Aided Mol. Design 6 1992 61 78
41. S. Ni Discovering potent small molecule inhibitors of cyclophilin A using de novo drug design approach J. Med. Chem. 52 2009 5295 5298
42. S. Bembenek Ligand efficiency and fragment-based drug discovery Drug Discov. Today 14 2009 278 283
43. A.C. Anderson The process of structure-based drug design Chem. Biol. 10 2003 787 797 (Pubitemid 37171897)
44. S.-Y. Huang Scoring functions and their evaluation methods for protein-ligand docking: recent advances and future directions Phys. Chem. Chem. Phys. 12 2010 12899 12908
45. L.A. Fenu Scoring functions H. Jhoti, A.R. Leach, Structure-Based Drug Discovery 2007 Springer pp. 223-245
46. S.F. Sousa Protein-ligand docking: current status and future challenges Proteins Struct. Funct. Bioinform. 65 2006 15 26 (Pubitemid 44320611)
47. D.B. Kitchen Docking and scoring in virtual screening for drug discovery: methods and applications Nat. Rev. Drug Discov. 3 2004 935 949 (Pubitemid 39529931)
48. P.L. Kastritis, and A.M.J.J. Bonvin Are scoring functions in protein-protein docking ready to predict interactomes? Clues from a novel binding affinity benchmark J. Proteome Res. 9 2010 2216 2225
49. A. Wlodawer, and J. Vondrasek Inhibitors of HIV-1 protease: a major success of structure-assisted drug design1 Annu. Rev. Biophys. Biomol. Struct. 27 1998 249 284 (Pubitemid 28286016)
50. D.B. Boyd How computational chemistry became important in the pharmaceutical industry K.B. Lipkowitz, Reviews in Computational Chemistry, Vol. 23 2007 Wiley pp. 401-443
51. E.E. Rutenber, and R.M. Stroud Binding of the anticancer drug ZD1694 to E. coli thymidylate synthase: assessing specificity and affinity Structure 4 1996 1317 1324 (Pubitemid 26420500)
52. D.B. Boyd, and M.M. Marsh The history of computers in pharmaceutical research and development S. Ekins, B. Wang, Computer Applications in Pharmaceutical Research and Development 2006 Wiley pp. 1-50
53. T. De Paulis Drug evaluation: PRX-00023, a selective 5-HT1A receptor agonist for depression Curr. Opin. Investig. Drugs 8 2007 78 86 (Pubitemid 46453648)
54. Y. Martin Let's not forget tautomers J. Computer-Aided Mol. Design 23 2009 693 704
55. C. Temperini Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference Bioorg. Med. Chem. 17 2009 1214 1221
56. A.E. Cho Importance of accurate charges in molecular docking: quantum mechanical/molecular mechanical (QM/MM) approach J. Comput. Chem. 26 2005 915 931 (Pubitemid 40860395)
57. T. ten Brink, and T.E. Exner Influence of protonation, tautomeric, and stereoisomeric states on protein-ligand docking results J. Chem. Inform. Modeling 49 2009 1535 1546